Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21233083
Conclusion of this study
DHA supplementation improves liver steatosis and insulin sensitivity in children with NAFLD.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study